Cart
0

Smart Insulin or Glucose Responsive Insulin Market by Type (Rapid Acting, Intermediate Acting, Long Acting, Short Acting and Premixed Type), Diseases (Type 1 and Type 2 Diabetes) and Deliver Devices (Smart Insulin Pen, Smart Insulin Pump and Smart Insulin Patch Or Microneedle Array Patch) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_181674
Pages: NA
Dec 2018 | 1704 Views
 
Author's : NA
Tables: NA
Charts: NA
 

The development of smart insulin is accelerating the growth of healthcare and digital science leading to cures and treatments of patients with Type 1 and Type 2 diabetes by promoting upcoming approaches. Smart insulin works accordingly in response to blood glucose concentration; the higher the blood glucose more concentration of insulin is released and less insulin is released in response to lower blood glucose. The emergence of these healthcare-cum-technology have addressed the soaring need for better diagnostics as compared to current insulin supply since it reduces the diabetes related stress, decreases the need of regular blood tests, no other insulin supplement is required, prevents carb counting and smart insulin injection can be applied only once a day. Minimal weight gain and reduced risk of hypoglycemia are recent success that has opened new avenues for smart insulin usage.

The global smart insulin market is expected to register substantial growth in the near future, attributed to rising prevalence of diabetic patients, advancements in technological delivery devices, high demand for better efficacy products and replacement of painful injections with technology advancements. In addition, favorable government policies and increased collaborations among companies and research institutions are driving factors of market. However, high investment cost, more manufacturing complexities and stringent regulatory requirements for product approval are factors that can hinder the market growth. Growing personalized awareness and spreading of technology in emerging economies leads to prospering of this market.

The report segments the smart insulin market on the basis of types, diseases, delivery devices and geography. On the basis of types, market is diverged into rapid acting, intermediate acting, long acting, short acting and premixed type of insulin. Based on diseases, the market is segmented into Type 1 diabetes and Type 2 diabetes. The market segmentations on the basis of delivery devices are smart insulin pen, smart insulin pump and smart insulin patch or microneedle array patch. The market is analyzed across geographical regions namely North America, Europe, Asia-Pacific, and LAMEA.

Healthcare giants such as Juvenile Diabetes Research Foundation and SmartCells are collaborated in a partnership where SmartCells received $1 million fund for safety and efficacy studies for preclinical testing of smart insulin on animals. Furthermore, Juvenile Diabetes Research Foundation has introduced Glucose Responsive Insulin Grand Challenge Prize which draws the group of scientists to this innovative field.

Comprehensive competitive analysis and profiles of major market players such as Juvenile Diabetes Research Foundation Ltd, Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Merck & Co., Inc., and MannKind Corporation are provided in this report. Other companies undergoing the clinical trials are ADOCIA, Biodel Inc., Biocon and Halozyme, Inc. is also provided in this report.

KEY BENEFITS FOR STAKEHOLDERS:

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global smart insulin market.
In-depth analysis has been done in this report by constructing market estimations for the key market segments between 2014 and 2022
This study evaluating competitive landscape and value chain has been taken into account to help in understanding the competitive environment across the geographies
Region-wise and country-wise global smart insulin market conditions are comprehensively analyzed in this report.
Comprehensive analysis of all regions are provided that determines the prevailing opportunities in these geographies
An in-depth analysis of current research and clinical developments within global smart insulin market is provided with key market dynamic factors that help in understanding the behaviour of the market

SMART INSULIN OR GLUCOSE RESPONSIVE INSULIN MARKET KEY SEGMENTS:

Market by Types

  • Rapid Acting
  • Intermediate Acting
  • Long Acting
  • Short Acting
  • Premixed Type

Market by Diseases

  • Type 1 Diabetes
  • Type 2 Diabetes

Market by Delivery Devices

  • Smart Insulin Pen
  • Smart Insulin Patch or Microneedle Array Patch
  • Smart Insulin Pump

Market byGeography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • U.K.
    • Germany
    • France
    • Others
  • Asia-Pacific
    • Japan
    • India
    • China
    • Others
  • LAMEA
    • Brazil
    • U.A.E
    • Africa
    • Others
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request TOC/Sample

Request Customization

Request TOC/Sample

OR

Purchase Full Report of
Smart Insulin or Glucose Responsive Insulin Market- Global Opportunity Analysis and Industry Forecast, 2014 - 2022

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4833
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5805
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $8096
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo